Immunovant Q1 Net Income USD -153.224 Million Vs. IBES Estimate USD -130.2 Million
IMVT•Q1 earnings details
Aug. 6 (Reuters) - Immunovant Q1 operating expenses were USD 160.323 million.
- Q1 basic EPS: USD -0.75
IMVT•IMVT•IMVT•Aug. 6 (Reuters) - Immunovant Q1 operating expenses were USD 160.323 million.
